Great comparison..But I got a better one...How many people will use their product compared to Atossa?
But you are overly correct on one matter. You get the support of these folks and you establish a base. But I read the press release and the one striking statement that is the crux of the matter was, " The decision was the result of an extensive view of clinical evidence." This is the mountain Atossa has to climb for the Cignas
of this world to support them. It is happening as we speak as the greater number of tests give Atossa the clinical data to impress. It's coming.
The similarities between BEAT and ATOS is uncanny...both were about $70-80 mil market cap, both low traded stocks, both provide medical devices. BEAT is up 85% since June 10th after United healthcare news.
ATOS has got Millinium healthcare, Healthsmart health, Fisher Health...who is next.
My thought is that ATOS has a superior product with bigger potential than BEAT.
Unfortunately no, I was not in BEAT before the spike.